Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Alternative pharmacologic therapy for aggressive central giant cell granuloma: denosumab.

Alternative pharmacologic therapy for aggressive central giant cell granuloma: denosumab. J Oral Maxillofac Surg. 2014 Jul; 72(7):1301-9.

View in: PubMed

© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.